Physician's Weekly4d
Addressing Acute Pain & Related Challenges: Will Recent FDA Approval of a Novel Non-Opioid Analgesic Be a Game Changer?
FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve ...
Clinical Pain Advisor17d
Sublingual Sufentanil Provides No Additional Pain Relief Over Standard Trauma Care
In moderate to severe pain from blunt trauma, sublingual sufentanil was not more effective than standard care in reducing pain at 30 minutes.
Pharmacy owner, three others held for illegal sale of intoxication drug
Trichy: Trichy city police have busted an illegal intoxicating drug racket that targeted youths addicted to narcotic ...
Business Wire24d
Tris Pharma Announces Positive Results from ALLEVIATE-2 Phase 3 Pivotal Trial for Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of ...
“We are in desperate need of effective medications that provide opioid-level analgesia while minimizing the risk of misuse and abuse,” said Jeff Gudin, M.D., anesthesiologist at the University ...
EurekAlert!13d
BU researcher receives distinguished investigator award to study novel therapeutics targets for chronic pain conditions
Venetia Zachariou, PhD, Edward Avedisian Professor and chair of pharmacology, physiology & biophysics at Boston University Chobanian & Avedisian School of Medicine, has received a Distinguished ...